Idexx Laboratories's market cap is currently $36.77B. The company's EPS TTM is $10.667; its P/E ratio is 42.28; Idexx Laboratories is scheduled to report earnings on February 3, 2025, and the estimated EPS forecast is $2.86. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.66B	$ 3.37B	$ 3.22B	$ 2.71B	$ 2.41B
Gross Profit	$ 2.19B	$ 2.00B	$ 1.89B	$ 1.57B	$ 1.37B
Operating Income	$ 1.10B	$ 898.76M	$ 932.03M	$ 694.52M	$ 552.85M
EBITDA	$ 1.22B	$ 1.01B	$ 1.04B	$ 793.81M	$ 643.68M
Net Income	$ 845.04M	$ 679.09M	$ 744.85M	$ 581.78M	$ 427.72M
Balance Sheet
Cash & Short-Term Investments	$ 453.93M	$ 112.55M	$ 144.45M	$ 383.93M	$ 90.33M
Total Assets	$ 3.26B	$ 2.75B	$ 2.44B	$ 2.29B	$ 1.83B
Total Debt	$ 1.07B	$ 1.35B	$ 923.70M	$ 908.48M	$ 987.67M
Net Debt	$ 613.42M	$ 1.24B	$ 779.25M	$ 524.55M	$ 897.35M
Total Liabilities	$ 1.78B	$ 2.14B	$ 1.75B	$ 1.66B	$ 1.65B
Stockholders' Equity	$ 1.48B	$ 608.74M	$ 689.99M	$ 632.09M	$ 177.47M
Cash Flow
Free Cash Flow	$ 772.88M	$ 394.15M	$ 636.00M	$ 540.44M	$ 303.93M
Operating Cash Flow	$ 906.51M	$ 542.98M	$ 755.55M	$ 648.06M	$ 459.16M
Investing Cash Flow	$ -125.25M	$ -195.35M	$ -292.97M	$ -109.38M	$ -205.53M
Financing Cash Flow	$ -442.00M	$ -370.94M	$ -697.41M	$ -248.42M	$ -286.41M

Currency in USD

Idexx Laboratories Earnings and Revenue History

Income Statement >

Idexx Laboratories Debt to Assets

Balance Sheet >

Idexx Laboratories Cash Flow

Cash Flow >

Idexx Laboratories Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing